Hunter Advisors is pleased to offer for sale the 111-room TownePlace Suites by Marriott Bridgewater Branchburg, ideally located within the Bridgewater–Branchburg, NJ submarket, which boasts a varied demand base supported by a strong presence of corporate, pharmaceutical, and life-sciences businesses. The institutional quality, extended-stay Hotel opened in 2018, and is situated adjacent to Roche Molecular Systems and proximate to major employers such as Eli Lilly, Johnson & Johnson, Thermo Fisher Scientific, and Bausch Health. The property’s excellent physical condition, combined with its positioning in an established market with robust supply and demand fundamentals, presents a compelling investment opportunity.
- Institutional quality, extended stay positioned, Marriott branded Hotel
- Opportunity to unlock additional upside as the the Hotel has grown total revenue 4.8% since year-end 2025 to $4,026,733 and NOI 19.3% to $1,205,506 (TTM July 2026), expanding margin from 26.3% to 29.9%
- Located immediately adjacent to Roche Molecular Systems and situated among an established corporate, pharmaceutical, and life-science corridor providing a diverse demand base
- No capex due until 2029 due to the hotel's institutional quality and excellent condition
- Offered at a discount to today’s replacement cost
- High-barrier-to-entry submarket with no new hotel supply in the pipeline
